Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-κB in malignant melanoma cells
- 1 March 2001
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 280 (3) , C659-C676
- https://doi.org/10.1152/ajpcell.2001.280.3.c659
Abstract
The transcription factor nuclear factor-κB (NF-κB) is constitutively activated in malignancies from enhanced activity of inhibitor of NF-κB (IκB) kinase, with accelerated IκBα degradation. We studied whether redox signaling might stimulate these events. Cultured melanoma cells generated superoxide anions (O[Formula: see text]) without serum stimulation. O[Formula: see text]generation was reduced by the NAD(P)H:quinone oxidoreductase (NQO) inhibitor dicumarol and the quinone analog capsaicin, suggesting that electron transfer from NQO through a quinone-mediated pathway may be an important source of endogenous reactive oxygen species (ROS) in tumor cells. Treatment of malignant melanoma cells with the H2O2 scavenger catalase, the sulfhydryl donor N-acetylcysteine, the glutathione peroxidase mimetic ebselen, or dicumarol decreased NF-κB activation. Catalase, N-acetylcysteine, ebselen, dicumarol, and capsaicin also inhibited growth of melanoma and other malignant cell lines. These results raise the possibility that ROS produced endogenously by mechanisms involving NQO can constitutively activate NF-κB in an autocrine fashion and suggest the potential for new antioxidant strategies for interruption of oxidant signaling of melanoma cell growth.Keywords
This publication has 57 references indexed in Scilit:
- NAD(P)H: QUINONE OXIDOREDUCTASE POLYMORPHISM AND LUNG CANCER IN TAIWANJournal of Toxicology and Environmental Health, Part A, 1999
- Quinone Reductase Inhibitors Block SAPK/JNK and NFκB Pathways and Potentiate ApoptosisPublished by Elsevier ,1999
- Interleukin-1β and Reactive Oxygen Species Mediate Activation of c-Jun NH2-Terminal Kinases, in Human Epithelial Cells, by Two Independent PathwaysBiochemical and Biophysical Research Communications, 1998
- Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.Journal of Clinical Investigation, 1997
- NF-κB Activation: The IκB Kinase Revealed?Cell, 1997
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Constitutive and Cytokine-induced Expression of the Melanoma Growth Stimulatory Activity/GROα Gene Requires Both NF-κB and Novel Constitutive FactorsPublished by Elsevier ,1995
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994